reduct number cell product peripher blood patient viscer leishmaniasi pbmc patient viscer leishmaniasi VL success antimoni therapi phenotyp abil ifn-gamma pha leishmani Ag agreement result studi pbmc activ VL patient prolif respons ifn-gamma product healthi control level cell normal rang signific decreas cell helper-induc healthi individu inhibit cellular respons lymphokin secret level cell pbmc VL patient normal rang success chemotherapi pbmc activ VL patient adher cell nonadher cell non-adher subpopul result cell deplet reconstitut experi product nonadher cell pha adher cell product nonadher cell respons specif Ag contrast cell inhibit ag-driven product nonadher cell mitogen-stimul secret nonadher cell ag-specif product cell 